Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS)
CNY 40.45
(0.12%)
CNY 40.45
(0.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.89 Billion CNY | 20.58% |
| 2022 | 1.56 Billion CNY | 24.85% |
| 2021 | 1.25 Billion CNY | 14.94% |
| 2020 | 1.09 Billion CNY | 51.8% |
| 2019 | 720.62 Million CNY | 24.87% |
| 2018 | 577.1 Million CNY | -29.34% |
| 2017 | 816.7 Million CNY | 5.18% |
| 2016 | 776.45 Million CNY | 28.4% |
| 2015 | 604.72 Million CNY | 11.0% |
| 2014 | 544.79 Million CNY | 7.9% |
| 2013 | 504.92 Million CNY | 41.08% |
| 2012 | 357.9 Million CNY | 22.87% |
| 2011 | 291.28 Million CNY | 27.32% |
| 2010 | 228.78 Million CNY | -51.91% |
| 2009 | 475.78 Million CNY | 19.61% |
| 2008 | 397.79 Million CNY | 178.04% |
| 2007 | 143.07 Million CNY | -49.83% |
| 2006 | 285.18 Million CNY | -5.36% |
| 2005 | 301.32 Million CNY | 37.36% |
| 2004 | 219.37 Million CNY | -9.46% |
| 2003 | 242.3 Million CNY | 25.34% |
| 2002 | 193.31 Million CNY | 17.27% |
| 2001 | 164.85 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.79 Billion CNY | 5.39% |
| 2024 Q2 | 1.7 Billion CNY | -13.61% |
| 2024 Q1 | 1.97 Billion CNY | 4.4% |
| 2023 Q2 | 1.71 Billion CNY | 0.97% |
| 2023 Q4 | 1.89 Billion CNY | 6.77% |
| 2023 FY | 1.89 Billion CNY | 20.58% |
| 2023 Q1 | 1.69 Billion CNY | 8.09% |
| 2023 Q3 | 1.77 Billion CNY | 3.48% |
| 2022 Q2 | 1.28 Billion CNY | -2.35% |
| 2022 Q4 | 1.56 Billion CNY | 6.84% |
| 2022 Q3 | 1.46 Billion CNY | 14.72% |
| 2022 FY | 1.56 Billion CNY | 24.85% |
| 2022 Q1 | 1.31 Billion CNY | 4.33% |
| 2021 Q4 | 1.25 Billion CNY | 6.17% |
| 2021 FY | 1.25 Billion CNY | 14.94% |
| 2021 Q2 | 1.18 Billion CNY | -1.86% |
| 2021 Q1 | 1.2 Billion CNY | 10.42% |
| 2021 Q3 | 1.18 Billion CNY | -0.1% |
| 2020 Q4 | 1.09 Billion CNY | 23.52% |
| 2020 Q2 | 776.47 Million CNY | 1.43% |
| 2020 Q3 | 885.65 Million CNY | 14.06% |
| 2020 Q1 | 765.53 Million CNY | 6.23% |
| 2020 FY | 1.09 Billion CNY | 51.8% |
| 2019 Q3 | 644.74 Million CNY | 6.55% |
| 2019 Q1 | 553.93 Million CNY | -4.02% |
| 2019 FY | 720.62 Million CNY | 24.87% |
| 2019 Q4 | 720.62 Million CNY | 11.77% |
| 2019 Q2 | 605.1 Million CNY | 9.24% |
| 2018 FY | 577.1 Million CNY | -29.34% |
| 2018 Q3 | 533.67 Million CNY | -28.52% |
| 2018 Q2 | 746.57 Million CNY | 4.73% |
| 2018 Q1 | 712.85 Million CNY | -12.72% |
| 2018 Q4 | 577.1 Million CNY | 8.14% |
| 2017 FY | 816.7 Million CNY | 5.18% |
| 2017 Q4 | 816.7 Million CNY | 9.75% |
| 2017 Q1 | 757.64 Million CNY | -2.42% |
| 2017 Q3 | 744.13 Million CNY | 2.04% |
| 2017 Q2 | 729.27 Million CNY | -3.74% |
| 2016 Q1 | 633.54 Million CNY | 4.77% |
| 2016 FY | 776.45 Million CNY | 28.4% |
| 2016 Q4 | 776.45 Million CNY | 14.62% |
| 2016 Q3 | 677.4 Million CNY | 5.96% |
| 2016 Q2 | 639.28 Million CNY | 0.91% |
| 2015 Q2 | 578.17 Million CNY | -6.5% |
| 2015 Q4 | 604.72 Million CNY | 0.24% |
| 2015 FY | 604.72 Million CNY | 11.0% |
| 2015 Q1 | 618.37 Million CNY | 13.51% |
| 2015 Q3 | 603.25 Million CNY | 4.34% |
| 2014 Q3 | 503.74 Million CNY | -4.01% |
| 2014 Q2 | 524.77 Million CNY | 0.4% |
| 2014 Q1 | 522.67 Million CNY | 3.52% |
| 2014 FY | 544.79 Million CNY | 7.9% |
| 2014 Q4 | 544.79 Million CNY | 8.15% |
| 2013 FY | 504.92 Million CNY | 41.08% |
| 2013 Q4 | 504.92 Million CNY | 3.43% |
| 2013 Q3 | 488.15 Million CNY | -13.4% |
| 2013 Q2 | 563.66 Million CNY | 8.06% |
| 2013 Q1 | 521.62 Million CNY | 45.75% |
| 2012 Q3 | 348.6 Million CNY | -7.98% |
| 2012 FY | 357.9 Million CNY | 22.87% |
| 2012 Q4 | 357.9 Million CNY | 2.67% |
| 2012 Q1 | 398.58 Million CNY | 36.84% |
| 2012 Q2 | 378.84 Million CNY | -4.95% |
| 2011 Q1 | 312.19 Million CNY | 36.46% |
| 2011 FY | 291.28 Million CNY | 27.32% |
| 2011 Q4 | 291.28 Million CNY | -8.59% |
| 2011 Q3 | 318.65 Million CNY | -8.65% |
| 2011 Q2 | 348.82 Million CNY | 11.74% |
| 2010 Q1 | 533.49 Million CNY | 12.13% |
| 2010 Q2 | 356.25 Million CNY | -33.22% |
| 2010 Q3 | 423.39 Million CNY | 18.85% |
| 2010 Q4 | 228.78 Million CNY | -45.96% |
| 2010 FY | 228.78 Million CNY | -51.91% |
| 2009 Q3 | 483.84 Million CNY | 3.96% |
| 2009 Q4 | 475.78 Million CNY | -1.67% |
| 2009 Q2 | 465.4 Million CNY | -24.01% |
| 2009 Q1 | 612.42 Million CNY | 53.95% |
| 2009 FY | 475.78 Million CNY | 19.61% |
| 2008 Q2 | 443.57 Million CNY | 104.3% |
| 2008 Q1 | 217.12 Million CNY | 51.76% |
| 2008 FY | 397.79 Million CNY | 178.04% |
| 2008 Q4 | 397.79 Million CNY | -7.53% |
| 2008 Q3 | 430.16 Million CNY | -3.02% |
| 2007 Q3 | 131.78 Million CNY | -59.48% |
| 2007 Q1 | 282.07 Million CNY | -1.09% |
| 2007 Q2 | 325.25 Million CNY | 15.31% |
| 2007 FY | 143.07 Million CNY | -49.83% |
| 2007 Q4 | 143.07 Million CNY | 8.56% |
| 2006 Q2 | 255.57 Million CNY | -17.35% |
| 2006 Q4 | 285.18 Million CNY | -2.53% |
| 2006 Q3 | 292.57 Million CNY | 14.48% |
| 2006 FY | 285.18 Million CNY | -5.36% |
| 2006 Q1 | 309.22 Million CNY | 2.62% |
| 2005 Q1 | 193.33 Million CNY | -11.87% |
| 2005 Q3 | 345.43 Million CNY | 60.36% |
| 2005 Q4 | 301.32 Million CNY | -12.77% |
| 2005 FY | 301.32 Million CNY | 37.36% |
| 2005 Q2 | 215.41 Million CNY | 11.42% |
| 2004 Q4 | 219.37 Million CNY | 26.5% |
| 2004 Q2 | 235.54 Million CNY | -57.55% |
| 2004 FY | 219.37 Million CNY | -9.46% |
| 2004 Q1 | 554.91 Million CNY | 129.01% |
| 2004 Q3 | 173.42 Million CNY | -26.37% |
| 2003 FY | 242.3 Million CNY | 25.34% |
| 2003 Q4 | 242.3 Million CNY | 0.0% |
| 2002 FY | 193.31 Million CNY | 17.27% |
| 2001 FY | 164.85 Million CNY | 0.0% |